Classic triad of bladder cancer includes
Reading File
Finding Sources
Finding Sources
Reading File
Finding Sources
The textbooks are very clear and consistent on this. Here is the complete, authoritative answer:
Classic Triad of Bladder Cancer
| # | Feature | Details |
|---|---|---|
| 1 | Painless gross hematuria | Most common presenting symptom - occurs in 85-90% of patients. Characteristically intermittent (not constant), and may be related to Valsalva maneuvers. The painless nature distinguishes it from renal calculi. |
| 2 | Irritative voiding symptoms | Frequency, urgency, and dysuria - in the absence of urinary tract infection. These are especially prominent with carcinoma in situ (CIS). |
| 3 | Obstructive symptoms / pelvic pain | Occur in advanced/invasive disease - flank pain (ureteral obstruction), pelvic pain, or lower limb edema from lymph node involvement. |
Key Points from Textbook Sources
- Hematuria is the cardinal symptom - any single episode of gross hematuria must be evaluated even if subsequent urinalysis is negative (Campbell-Walsh Wein Urology).
- Irritative symptoms without infection on urine culture is a hallmark that should raise suspicion for bladder cancer, particularly CIS (Sabiston Textbook of Surgery).
- The hematuria is typically gross, painless, and intermittent - microscopic hematuria carries a malignancy risk of 2.6-5.2%, while gross hematuria carries a 20.4% risk of malignancy.
- Bladder cancer is rarely incidentally discovered - unlike many other cancers, it almost always presents symptomatically.
Sources: Smith and Tanagho's General Urology (19th ed.); Campbell-Walsh Wein Urology; Sabiston Textbook of Surgery; Bailey and Love's Short Practice of Surgery (28th ed.); Schwartz's Principles of Surgery (11th ed.)
What are the risk factors for bladder cancer?
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Excellent detail from Campbell-Walsh Wein Urology. Here is the comprehensive answer:
Risk Factors for Bladder Cancer
1. Smoking (Most Important Modifiable Risk Factor)
- Accounts for 30-40% of all urothelial carcinomas
- Smokers have a 2-5x increased risk compared to non-smokers
- Mechanism: aromatic amines in tobacco smoke cause DNA adduction after hydroxylation
- Pipe and cigar smoking also increase risk, not just cigarettes
- Individuals with NAT2 slow acetylation polymorphisms are at particularly high risk when they smoke (reduced ability to detoxify aromatic amines)
2. Occupational Exposure (Second Most Common)
Workers in the following industries are at elevated risk due to aromatic hydrocarbon exposure:
| Industry | Examples |
|---|---|
| Dye & paint | Benzidine, 2-naphthylamine, 4-aminobiphenyl |
| Rubber industry | - |
| Leather/tanning | - |
| Gas and tar | - |
| Hairdressers | Hair dyes |
| Plumbers & painters | - |
The latency period between occupational exposure and tumor development can be 15-40 years.
3. Chronic Bladder Inflammation
- Schistosomiasis (S. haematobium) - predisposes specifically to squamous cell carcinoma; also synergizes with smoking to further increase risk
- Indwelling catheters (spinal cord injury patients)
- Bladder stones
- Recurrent UTIs leading to keratinizing squamous metaplasia
4. Drugs
| Drug | Mechanism / Risk |
|---|---|
| Cyclophosphamide | Phosphoramide mustard (mutagenic metabolite) causes 4.5x increased risk; dose-dependent; peaks at 10-14 years after treatment |
| Phenacetin (analgesic, withdrawn) | Chronic use linked to urothelial cancers |
| Pioglitazone (thiazolidinedione) | Controversial - some studies show modestly increased risk |
5. Radiation Exposure
- Pelvic radiotherapy (e.g., for cervical or prostate cancer): 1.5-4x increased risk
- Latency period is 15-30 years
- Atomic bomb survivors showed markedly elevated rates
6. Environmental Carcinogens
- Arsenic in drinking water - strongly associated; especially prevalent in West Bengal, Bangladesh, Taiwan, and parts of Chile
- Mechanism: oxidative stress, epigenetic effects, DNA repair alterations
7. Demographics / Non-modifiable Factors
- Male sex: 3-4x more common in men than women
- Age: Risk increases with advancing age (median diagnosis age ~65)
- White race: 3-4x more likely than Black males or white females
- First-degree relatives with bladder cancer: ~2x increased risk
8. Genetic Factors
- NAT2 (N-acetyltransferase 2) slow acetylation polymorphism - impairs detoxification of aromatic amines
- GSTM1 deletion - glutathione S-transferase deficiency
- Lynch syndrome (HNPCC) - particularly MSH2 mutation carriers have increased urothelial cancer risk
Memory Aid (Mnemonics)
"SCRAP-D": Smoking, Chemicals (occupational), Radiation, Arsenic, Parasites (schistosomiasis), Drugs (cyclophosphamide)
Sources: Campbell-Walsh Wein Urology; Bailey and Love's Short Practice of Surgery (28th ed.); Washington Manual of Medical Therapeutics; Grainger & Allison's Diagnostic Radiology
This is a shared conversation. Sign in to Orris to start your own chat.